Related Experiment Video
Updated: Jan 12, 2026

Comparison of Kinetic Characteristics of Footwork during Stroke in Table Tennis: Cross-Step and Chasse Step
Published on: June 16, 2021
Can table tennis protect the aging brain? A systematic review and meta-analysis in neurodegenerative diseases
Kinga Łosińska1, Adam Maszczyk2
1Gdańsk University of Physical Education and Sport, Gdańsk, Poland.
Background:
Table tennis (TT) is an increasingly investigated intervention for supporting cognitive, motor, and psychosocial functions in older adults with neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and dementia. However, evidence remains fragmented, and the effect sizes and reliability of TT-based programs remain unclear.
Materials And Methods:
Following PRISMA 2020 guidelines, a systematic search of four databases (PubMed, Scopus, Web of Science, SPORTDiscus) was conducted through June 30, 2025. Ten studies met inclusion criteria, with five eligible for quantitative synthesis. Random-effects meta-analyses (DerSimonian-Laird) were performed on cognitive and motor outcomes. Risk of bias was assessed using the JBI checklist, and certainty of evidence was graded using the GRADE framework. Out of 499 screened records, ten studies met the predefined eligibility criteria and were included in the systematic review. Of these, five studies provided sufficient statistical data for inclusion in the meta-analysis.
Results:
Meta-analysis revealed large effects for cognitive outcomes (MMSE: d = 1.44; MoCA: d = 1.31), motor function (UPDRS-III: d = 1.27), and dual-task gait (TUG: d = 0.93), with low-to-moderate heterogeneity estimated (I2 = 18-42 %), though given the small number of studies, these estimates warrant cautious interpretation. Sensitivity analyses confirmed the robustness of pooled effects. GRADE evaluations indicated moderate certainty. No serious adverse events were reported.
Conclusions:
Table tennis appears to be a safe, feasible, and effective non-pharmacological intervention for enhancing cognitive and motor outcomes in individuals with AD, PD, and dementia. Further high-quality trials with standardized protocols and mechanistic endpoints are needed to confirm these findings and expand clinical applicability. While preliminary findings suggest beneficial effects, the limited number of small trials, geographic concentration, and methodological limitations temper definitive conclusions.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Alzheimer's Disease: Treatment
Parkinson's Disease: Overview

